Biolife Solutions (BLFS) FCF Margin (2010 - 2026)

Biolife Solutions (BLFS) has reported FCF Margin for 17 consecutive years, with 18.64% the latest figure, recorded in Q2 2026.

• On a quarterly basis, FCF Margin fell 697.0% year-over-year to 18.64% in Q2 2026; TTM through Jun 2026 was 7.88%, a 644.0% decrease from a year earlier, with the FY2025 full-year figure at 11.06%, up 408.0% from the prior year.
• FCF Margin was 18.64% for Q2 2026 at Biolife Solutions, up from 2.39% in the prior quarter.
• Over five years, FCF Margin peaked at 27.71% in Q2 2024 and troughed at 29.49% in Q2 2022.
• A 5-year average of 3.31% and a median of 2.36% in 2022 frame the typical range for FCF Margin.
• Across the five-year window, FCF Margin sank 2649 bps in 2022 and surged 5620 bps in 2024, its largest moves.
• Over 5 years, FCF Margin stood at 8.26% in 2022, then dropped by 15 bps to 9.52% in 2023, then surged by 161 bps to 5.84% in 2024, then sank by 40 bps to 3.5% in 2025, then soared by 432 bps to 18.64% in 2026.
• The last three FCF Margin figures came in at 18.64% (Q2 2026), 2.39% (Q1 2026), and 3.5% (Q4 2025), per Business Quant data.